Imaging Brain Metabolism and Pathology in Alzheimer’s Disease with Positron Emission Tomography

Current Positron Emission Tomography (PET) biomarkers for Alzheimer’s disease (AD) assess either neuronal function, or associated pathological features of this common neurodegenerative disease. The most widely accepted clinical PET tool for AD is 18-fluorodeoxyglucose PET (FDG-PET), which measures c...

Descripción completa

Detalles Bibliográficos
Autores principales: Shokouhi, S, Claassen, D, Riddle, WR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204649/
https://www.ncbi.nlm.nih.gov/pubmed/25343059
http://dx.doi.org/10.4172/2161-0460.1000143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204649/
https://www.ncbi.nlm.nih.gov/pubmed/25343059
http://dx.doi.org/10.4172/2161-0460.1000143

Ejemplares similares